ResearcherSecond Hospital of Tianjin Medical UniversityActive in the last 2 years

Yaqing Wei

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5123709242. Sources: OpenAlex.

Their work

Papers: 3
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 7

Papers, trials and grants by year

2025: 2 papers · 2026: 1 paper

Papers 3

lncRNA-based prognostic model for pancreatic cancer centered on the TME with exploratory LLPS connections. Co-author DOI 10.3389/fonc.2026.1753321 ↗
Chemotherapy-associated mutational process signature and genomic alterations associated with outcome in metastatic pancreatic cancer. Co-author DOI 10.1007/s12094-025-03975-1 ↗
USP10 promotes the progression and attenuates gemcitabine chemotherapy sensitivity via stabilizing PLK1 in PDAC. Co-author DOI 10.1038/s41419-025-07757-z ↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Chenhui Zhang · 2 shared papers, 2025–2026 · strength 0.55
- Paper lncRNA-based prognostic model for pancreatic cancer centered on the TME with exploratory LLPS connections. DOI 10.3389/fonc.2026.1753321 ↗
- Paper USP10 promotes the progression and attenuates gemcitabine chemotherapy sensitivity via stabilizing PLK1 in PDAC. DOI 10.1038/s41419-025-07757-z ↗
Jinjin Sun · 2 shared papers, 2025 · strength 0.45
- Paper USP10 promotes the progression and attenuates gemcitabine chemotherapy sensitivity via stabilizing PLK1 in PDAC. DOI 10.1038/s41419-025-07757-z ↗
- Paper Chemotherapy-associated mutational process signature and genomic alterations associated with outcome in metastatic panc… DOI 10.1007/s12094-025-03975-1 ↗
Hao Huang · 1 shared paper, 2026 · strength 0.32
- Paper lncRNA-based prognostic model for pancreatic cancer centered on the TME with exploratory LLPS connections. DOI 10.3389/fonc.2026.1753321 ↗
Hao Yao · 1 shared paper, 2026 · strength 0.32
- Paper lncRNA-based prognostic model for pancreatic cancer centered on the TME with exploratory LLPS connections. DOI 10.3389/fonc.2026.1753321 ↗
Xuezhi Du · 1 shared paper, 2025 · strength 0.24
- Paper USP10 promotes the progression and attenuates gemcitabine chemotherapy sensitivity via stabilizing PLK1 in PDAC. DOI 10.1038/s41419-025-07757-z ↗
Zhijia Jiang · 1 shared paper, 2025 · strength 0.21
- Paper Chemotherapy-associated mutational process signature and genomic alterations associated with outcome in metastatic panc… DOI 10.1007/s12094-025-03975-1 ↗
Kaiqiang Wang · 1 shared paper, 2025 · strength 0.21
- Paper Chemotherapy-associated mutational process signature and genomic alterations associated with outcome in metastatic panc… DOI 10.1007/s12094-025-03975-1 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.